We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Industry Insights

How Metabolomic Biomarker Networks Could Help Diagnose Bladder Cancer
Industry Insight

We spoke to Dr. Maximilian Zucker to learn more metabolomic biomarker networks and the role that they could play in the future of diagnostics.

Read More

Data-Driven Medicine: The Role of AI in Cancer Diagnostics
Industry Insight

We find out how SOPHiA™, a recently introduced artificial intelligence platform, could help improve the adoption of liquid biopsies in hospitals.

Read More

First FDA Approval for NGS-based Companion Diagnostic
Industry Insight

To learn about some of the challenges met in achieving FDA approval, the advantages the test offers, and how its use can benefit non-small cell lung cancer patients, we spoke to Joydeep Goswami, president of Clinical Next Generation Sequencing and Oncology at Thermo Fisher Scientific.

Read More

Driving Forward Companion Diagnostics Development
Industry Insight

We spoke to Dr. Markus Tolnay and Mark Stevenson, to learn more about the NGS Companion Dx Center of Excellence Program and what it hopes to achieve.

Read More

The Role of Metabolomics in Diagnostics
Industry Insight

We spoke to Volker Pfahlert, numares AG, to learn about the role of metabolomics in diagnostics and the advantages it can offer over current methods.

Read More

Improving Prostate & Bladder Cancer Diagnosis
Industry Insight

We spoke to Nadia Whittley, CEO, Arquer Diagnostics, to learn about some of the current limitations of diagnosing bladder and prostate cancer, and how MCM5-ELISA tests could help.

Read More

Overcoming Problems in Biopharma with Mass Spectrometry
Industry Insight

SCIEX have launched their new X500B QTOF Mass Spectrometry System. To find out more, and to see how the new system helps over come current problems in biophama, we spoke to Farzana Azam, Senior Director of Pharmaceutical Business at SCIEX.

Read More

High Purity Plasma Extraction
Industry Insight

To learn about some of the challenges of extracting plasma from blood, and how a recently developed microfluidic device could help overcome some of these, we spoke to Dr. Weihua Li.

Read More

A New Weapon in the War Against Antibiotic Resistance
Industry Insight

We spoke to Bruce Savage, CEO at GFC Diagnostics to learn more about the MicroScreen test.

Read More

Verification of Scientific Methods and Results
Industry Insight

To find out about the sbv IMPROVER project and its aims, we spoke to Dr Julia Hoeng, Director of Systems Toxicology at PMI Research & Development.

Read More

 
Advertisement